Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment. (2024)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/psp4.13097
PubMed Identifier: 38108548
Publication URI: http://europepmc.org/abstract/MED/38108548
Type: Journal Article/Review
Volume: 13
Parent Publication: CPT: pharmacometrics & systems pharmacology
Issue: 3
ISSN: 2163-8306